EGFR mutations in non-small cell lung carcinomas may predict response to gefitinib: extension of an emerging paradigm
- PMID: 15731572
- DOI: 10.1097/01.pap.0000155052.68496.e4
EGFR mutations in non-small cell lung carcinomas may predict response to gefitinib: extension of an emerging paradigm
Comment on
-
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.N Engl J Med. 2004 May 20;350(21):2129-39. doi: 10.1056/NEJMoa040938. Epub 2004 Apr 29. N Engl J Med. 2004. PMID: 15118073
-
EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.Science. 2004 Jun 4;304(5676):1497-500. doi: 10.1126/science.1099314. Epub 2004 Apr 29. Science. 2004. PMID: 15118125
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous